Enter the labelled vial amount (often shown in mg)
None of these topical formulations are FDA-approved, which means the agency has not evaluated their safety, efficacy, or quality prior to marketing
Typical Protocol: Common research protocols use a loading phase of roughly 4-8 mg per week (split into 2-3 subcutaneous injections) for 4-6 weeks, followed by a maintenance phase of about 2-6 mg biweekly for another 4-8 weeks, with a full cycle running 8-14 weeks and at least 4 weeks off before repeating
In cases of HPA-D, it is often that cortisol remains elevated in the evening, preventing the necessary recovery to wake refreshed
it actively converts oxidised glutathione back into its reduced, biologically active form inside your cells
Learn more about our editorial process